Ci Private Wealth, LLC Sarepta Therapeutics, Inc. Transaction History

Ci Private Wealth, LLC

  • $69.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$113.33 - $163.85 $152,655 - $220,705
1,347 Added 20.78%
7,828 $1.24 Million
Q1 2024

May 09, 2024
BUY
$93.7 - $141.53 $46,100 - $69,632
492 Added 8.22%
6,481 $839,000
Q4 2023

Feb 09, 2024
BUY
$67.31 - $124.76 $130,648 - $242,159
1,941 Added 47.95%
5,989 $577,000
Q3 2023

Nov 03, 2023
BUY
$102.5 - $123.59 $414,920 - $500,292
4,048 New
4,048 $490,000
Q4 2022

Feb 15, 2023
BUY
$100.86 - $132.13 $396,783 - $519,799
3,934 New
3,934 $509,000

Others Institutions Holding SRPT

# of Institutions
532
Shares Held
84.5M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.15B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email